Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efficacy Trial of Ambisome Given Alone and Ambisome Given in Combination With Miltefosine for the Treatment of VL HIV Positive Ethiopian Patients.

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Medecins Sans Frontieres, Netherlands
London School of Hygiene and Tropical Medicine
Addis Ababa University
Institute of Tropical Medicine, Belgium
Slotervaart Hospital
University of Gondar
Information provided by (Responsible Party):
Drugs for Neglected Diseases
ClinicalTrials.gov Identifier:
NCT02011958
First received: November 18, 2013
Last updated: March 18, 2016
Last verified: March 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: April 2017
  Estimated Primary Completion Date: August 2016 (Final data collection date for primary outcome measure)